Terms: = Pancreatic cancer AND ETV6, TEL/ABL, 2120, ENSG00000139083, P41212, TEL AND Diagnosis
4 results:
1. Early-Onset Pancreas cancer: Clinical Descriptors, Genomics, and Outcomes.
Varghese AM; Singh I; Singh R; Kunte S; Chou JF; Capanu M; Wong W; Lowery MA; Stadler ZK; Salo-Mullen E; Saadat LV; Wei AC; Reyngold M; Basturk O; Benayed R; Mandelker D; Iacobuzio-Donahue CA; Kelsen DP; Park W; Yu KH; O'Reilly EM
J Natl Cancer Inst; 2021 Sep; 113(9):1194-1202. PubMed ID: 33755158
[TBL] [Abstract] [Full Text] [Related]
2. Salivary Gland cancer in the Era of Routine Next-Generation Sequencing.
Todorovic E; Dickson BC; Weinreb I
Head Neck Pathol; 2020 Jun; 14(2):311-320. PubMed ID: 32124419
[TBL] [Abstract] [Full Text] [Related]
3. The dilemma of "indeterminate" interpretations of pancreatic neuroendocrine tumors on fine needle aspiration.
Ahmed A; VandenBussche CJ; Ali SZ; Olson MT
Diagn Cytopathol; 2016 Jan; 44(1):10-3. PubMed ID: 26402138
[TBL] [Abstract] [Full Text] [Related]
4. Risk factors for developing a new venous thromboembolism in ambulatory patients with non-hematologic malignancies and impact on survival for gastroesophageal malignancies.
Shah MA; Capanu M; Soff G; Asmis T; Kelsen DP
J Thromb Haemost; 2010 Aug; 8(8):1702-9. PubMed ID: 20553384
[TBL] [Abstract] [Full Text] [Related]